Evolution of Intravenous Medication Errors and Preventive Systemic Defenses in Hospital Settings—A Narrative Review of Recent Evidence

Sini Kuitunen,Marja Airaksinen,Anna-Riia Holmström
DOI: https://doi.org/10.1097/pts.0000000000001222
2024-03-29
Journal of Patient Safety
Abstract:Intravenous (IV) drug administration has been associated with a high risk of medication errors (MEs) and other adverse drug events in hospital settings. 1–4 Observational multisite studies have reported a high prevalence of MEs and procedural failures, 5,6 while some have estimated that up to 10% of IV medication administrations include an error. 4 When compared to other administration routes, it has been found that errors are as much as five times more likely to occur when an IV route is used. 3 Moreover, many intravenously administered drugs are high-alert medications, bearing a heightened risk of causing significant patient harm if used in error. 7 Consequently, effective interventions to highlight and eliminate IV MEs within the medication management and use (MMU) process are needed to ensure medication safety in hospital settings. 8–15
health care sciences & services,health policy & services
What problem does this paper attempt to address?